LISRAYA | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

18 results for “LISRAYA”

Trials

Not yet recruiting

CTRI/2024/06/069512

Purgation with misraka sneha in treating rheumatoid arthritis

30 participants

Librata Endometrial Ablation Device Treatment to Reduce Menstrual Blood Loss

200 participants · First posted Oct 31, 2018

Librata Endometrial Ablation Device Treatment to Reduce Menstrual Blood Loss in Sites Across the United Kingdom

40 participants · First posted Nov 22, 2016

Organizations

Lisata Therapeutics

United States

News

View all 14 →

Roivant Launches LISRAYA in Dermatomyositis, Eyes Uveitis and FcRn Readouts

Immunovant Halts IMVT-1402 Development in Cutaneous Lupus After Phase 2 Proof-of-Concept Miss

Roivant's Mosliciguat Hits Phase 2 Endpoints in PH-ILD, Phase 3 PHrontier Enrolling

Page 1 of 2